Michelson Medical Research Foundation’s iShares Core S&P 500 ETF IVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,989
Closed -$8.42M 24
2025
Q1
$8.42M Hold
14,989
7.05% 6
2024
Q4
$8.82M Hold
14,989
7.4% 3
2024
Q3
$8.65M Hold
14,989
6.1% 6
2024
Q2
$8.2M Sell
14,989
-3,000
-17% -$1.58M 7.05% 5
2024
Q1
$9.46M Hold
17,989
5.73% 7
2023
Q4
$8.59M Hold
17,989
5.67% 6
2023
Q3
$7.73M Hold
17,989
5.22% 7
2023
Q2
$8.02M Hold
17,989
5.7% 9
2023
Q1
$7.39M Sell
17,989
-15,710
-47% -$6.3M 5.8% 9
2022
Q4
$12.9M Buy
+33,699
New +$13M 8.39% 5

Other funds holding IVV

Michelson Medical Research Foundation's IVV Position: Q2 2025 in Review

Michelson Medical Research Foundation sold out of iShares Core S&P 500 ETF (IVV) in Q2 2025, closing a stake of 14,989 shares — an estimated $8.42M sold.

Michelson Medical Research Foundation first reported a position in IVV in Q4 2022 and held it in 10 quarters. The position peaked at $12.9M in Q4 2022. 3,619 funds tracked by Wall St. Rank hold IVV as of Q2 2025.

  • Michelson Medical Research Foundation reported no remaining iShares Core S&P 500 ETF position as of Q2 2025 after selling out during the quarter.
  • Michelson Medical Research Foundation sold 14,989 iShares Core S&P 500 ETF shares in Q2 2025, an estimated $8.42M.
  • Michelson Medical Research Foundation first reported a position in iShares Core S&P 500 ETF in Q4 2022 and held it in 10 quarters.
  • Michelson Medical Research Foundation's iShares Core S&P 500 ETF position peaked at $12.9M in Q4 2022.
  • 3,619 funds tracked by Wall St. Rank held iShares Core S&P 500 ETF as of Q2 2025.

Based on Michelson Medical Research Foundation's 13F filing for Q2 2025, filed 14 Aug 2025.